Nitrile oxide compound

US12209062B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12209062-B2
Application numberUS-202017104957-A
CountryUS
Kind codeB2
Filing dateNov 25, 2020
Priority dateMay 28, 2018
Publication dateJan 28, 2025
Grant dateJan 28, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides a compound represented by formula (I) wherein symbols in the formula are as defined in the specification.

First claim

Opening claim text (preview).

The invention claimed is: 1. A compound represented by formula (I): wherein Rf 1 is a monovalent or divalent perfluoropolyether group; R 2 and R 3 are each independently at each occurrence a hydrogen atom or a hydrocarbon group; R 4 is each independently at each occurrence —S—, —NR 7 —, or —O—P(═O) (OR 8 )—; R 5 is each independently at each occurrence: wherein R 6 is a divalent organic group; R 11 is a hydrogen atom or an alkyl group having 1 to 6 carbon atoms; R 12 is a hydrogen atom or an alkyl group having 1 to 6 carbon atoms; R 13 is a hydrogen atom or an alkyl group having 1 to 6 carbon atoms; and R 14 is a hydrogen atom or an alkyl group having 1 to 6 carbon atoms; R 7 is each independently at each occurrence a hydrogen atom or a hydrocarbon group; R 8 is each independently at each occurrence a hydrocarbon group; and s is 1 or 2. 2. The compound according to claim 1 , wherein R 4 is —S—. 3. The compound according to claim 1 , wherein R 6 is an alkylene group, or an alkyleneoxy group. 4. A compound represented by formula (II): wherein Rf 1 is a monovalent or divalent perfluoropolyether group; R 2 and R 3 each independently at each occurrence is a hydrogen atom or a hydrocarbon group; R 4 is each independently at each occurrence —S—, —NR 7 —, or —O—P(═O) (OR 8 )—; R 5 is each independently at each occurrence: wherein R 6 is a divalent organic group; R 11 is a hydrogen atom or an alkyl group having 1 to 6 carbon atoms; R 12 is a hydrogen atom or an alkyl group having 1 to 6 carbon atoms; R 13 is a hydrogen atom or an alkyl group having 1 to 6 carbon atoms; and R 14 is a hydrogen atom or an alkyl group having 1 to 6 carbon atoms; R 7 is each independently at each occurrence a hydrogen atom or a hydrocarbon group; R 8 is each independently at each occurrence a hydrocarbon group; and s is 1 or 2. 5. A composition comprising one or more compounds according to claim 1 for being applied to a material comprising a group having reactivity with a nitrile oxide group. 6. A compound represented by formula (I): wherein Rf 1 is a monovalent or divalent perfluoropolyether group; R 2 and R 3 are each independently at each occurrence a hydrogen atom or a hydrocarbon group; R 4 is —O—; R 5 is each independently at each occurrence: wherein R 6 is —R 16 — —R 16 ′—R 18 —, or —R 16 —R 18 —R 16 — wherein R 16 is an alkylene group having 1 to 20 carbon atoms, R 16 ′ is a branched alkylene group having 3 to 20 carbon atoms, and R 18 is an oxygen atom; R 11 is a hydrogen atom or an alkyl group having 1 to 6 carbon atoms; R 12 is a hydrogen atom or an alkyl group having 1 to 6 carbon atoms; R 13 is a hydrogen atom or an alkyl group having 1 to 6 carbon atoms; and R 14 is a hydrogen atom or an alkyl group having 1 to 6 carbon atoms; and s is 1 or 2. 7. A compound represented by formula (II): wherein Rf 1 is a monovalent or divalent perfluoropolyether group; R 2 and R 3 each independently at each occurrence is a hydrogen atom or a hydrocarbon group; R 4 is —O—; R 5 is each independently at each occurrence: wherein R 6 is —R 16 — —R 16 ′—R 18 —, or R 16 —R 18 —R 16 — wherein R 16 is an alkylene group having 1 to 20 carbon atoms, R 16 ′ is a branched alkylene group having 3 to 20 carbon atoms, and R 18 is an oxygen atom; R 11 is a hydrogen atom or an alkyl group having 1 to 6 carbon atoms; R 12 is a hydrogen atom or an alkyl group having 1 to 6 carbon atoms; R 13 is a hydrogen atom or an alkyl group having 1 to 6 carbon atoms; and R 14 is a hydrogen atom or an alkyl group having 1 to 6 carbon atoms; and s is 1 or 2.

Assignees

Inventors

Classifications

  • C09D5/00Primary

    Coating compositions, e.g. paints, varnishes or lacquers, characterised by their physical nature or the effects produced {(electrically insulating plastics, resins or waxes H01B3/30)}; Filling pastes · CPC title

  • of a saturated carbon skeleton · CPC title

  • to oxygen atoms · CPC title

  • the carbon skeleton being acyclic and saturated · CPC title

  • with the nitrogen atoms further bound to oxygen atoms · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12209062B2 cover?
The present invention provides a compound represented by formula (I) wherein symbols in the formula are as defined in the specification.
Who is the assignee on this patent?
Tokyo Inst Tech, Daikin Ind Ltd
What technology area does this patent fall under?
Primary CPC classification C09D5/00. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 5 related publications on this page (citations in our corpus or others sharing the same primary CPC).